SEAS

Vytorin Researcher Accuses Congress of Harassment

21 Comments

By Ed Silverman // September 18th, 2008 // 8:48 am

The Trouble With Merck: One Analyst Turns Sour

29 Comments

By Ed Silverman // September 10th, 2008 // 10:06 am

Hearty News From Europe’s Cardiology Meeting

Make a comment

By Ed Silverman // August 31st, 2008 // 10:36 am

Only Your Cardiologist Knows For Sure?

1 Comment

By Ed Silverman // August 28th, 2008 // 7:03 am

FDA Investigates Vytorin Link To Cancer

4 Comments

By Ed Silverman // August 21st, 2008 // 4:32 pm

Congress Miffed Over Vytorin Report & Consultant

4 Comments

By Ed Silverman // August 21st, 2008 // 12:40 pm

The Vytorin Limbo: Going Just A Little Lower

6 Comments

By Ed Silverman // August 19th, 2008 // 8:01 am

Congress Asks FDA For Vytorin Cancer Data

15 Comments

By Ed Silverman // July 31st, 2008 // 9:29 pm

The Vytorin Anomaly: ‘You’ve Got To Be Worried’

25 Comments

By Ed Silverman // July 26th, 2008 // 8:35 am

Fred Hassan Sidesteps Vytorin Cancer Risk

23 Comments

By Ed Silverman // July 21st, 2008 // 7:03 pm

Older posts »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/

-->